Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Certified by Founder
Lodge
Encellin
start up
United States
- Mountain View
- 14/12/2023
- Unknown
- $9,900,000
Encellin is focused on advancing next generation therapies, starting with endocrine disorders.
We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases.
- Industry Biotechnology Research
- Website https://www.encellin.com/
- LinkedIn https://www.linkedin.com/company/encellin/about/
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)